Ascentage Pharma Group International (HKG:6855)
31.26
+0.70 (2.29%)
Oct 21, 2026, 4:08 PM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 828 employees as of June 30, 2026. The number of employees increased by 61 or 7.95% since the number was reported on December 31, 2025. That makes Ascentage Pharma Group International the 16,264th largest employer in the world and 1,091st in Hong Kong.
Employees
828
Change
61
Growth
7.95%
Revenue / Employee
896.02K HKD
Profits / Employee
-2.05M HKD
Market Cap
11.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 828 | 61 | 7.95% |
| Dec 31, 2025 | 767 | 200 | 35.27% |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 1,999 |
| Everest Medicines | 812 |
| Alphamab Oncology | 515 |
| Suzhou Ribo Life Science | 453 |
| HBM Holdings | 327 |
| Duality Biotherapeutics | 266 |
| CStone Pharmaceuticals | 147 |
Ascentage Pharma Group International News
- 9 hours ago - Ascentage Pharma's Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL - GlobeNewsWire
- 5 days ago - Ascentage Pharma initiated with an Outperform at William Blair - TheFly
- 6 days ago - Ascentage Pharma initiated with a Buy at Citi - TheFly
- 8 days ago - Ascentage Pharma initiated with an Outperform at Citizens - TheFly
- 10 days ago - 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead - MarketBeat
- 12 days ago - Ascentage Pharma price target lowered to $33 from $46 at JPMorgan - TheFly
- 15 days ago - 3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight - MarketBeat
- 6 weeks ago - Ascentage Pharma to Participate in Four Upcoming Investor Conferences - GlobeNewsWire